» Articles » PMID: 39796592

Association Between Serum Folate Concentrations and 10-Year Stroke Risk in a Prospective Community Cohort: Mediation and Interaction Analyses

Overview
Journal Nutrients
Date 2025 Jan 11
PMID 39796592
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between folate concentrations and stroke risk remains unestablished, and the mediation effect of homocysteine (Hcy) and interaction effect of methylenetetrahydrofolate reductase () gene polymorphism has yet to be investigated. This cohort study involved 4903 subjects derived from a Chinese community population. The association between folate and first stroke was examined in Cox proportional hazard regression models. The mediation analyses involving Hcy and the undiscovered modification of the genotype were assessed. The mean (SD) age of subjects was 56.7 (8.8) years old, and 37.0% were male. A total of 407 strokes, 375 ischemic strokes and 47 hemorrhagic strokes occurred during the mean (SD) follow-up of 9.3 (1.8) years. The participants in the highest folate quartile (≥8.2 ng/mL) exhibited a lower stroke risk compared to those in the lowest quartile (hazard ratio [HR]: 0.68, 95% confidence interval [CI]: 0.50-0.93, = 0.017; for trend = 0.009). Hcy significantly mediated 14.51% of the relationship between folate and stroke in the fully adjusted model. Only in individuals with the genotype but not / genotype was folate adversely correlated with stroke (HR: 0.88, 95% CI: 0.79-0.97, for interaction = 0.026) and ischemic stroke (HR: 0.88, 95% CI: 0.80-0.98, for interaction = 0.035). Insufficient folate concentrations were associated with a heightened 10-year stroke risk, in which Hcy concentrations played a crucial mediating role. gene polymorphism could potentially modify the folate-stroke relationship.

References
1.
Yuan S, Mason A, Carter P, Burgess S, Larsson S . Homocysteine, B vitamins, and cardiovascular disease: a Mendelian randomization study. BMC Med. 2021; 19(1):97. PMC: 8063383. DOI: 10.1186/s12916-021-01977-8. View

2.
Bennett D, Parish S, Millwood I, Guo Y, Chen Y, Turnbull I . MTHFR and risk of stroke and heart disease in a low-folate population: a prospective study of 156 000 Chinese adults. Int J Epidemiol. 2023; 52(6):1862-1869. PMC: 10749746. DOI: 10.1093/ije/dyad147. View

3.
Wu D, Yin R, Deng J . Homocysteine, hyperhomocysteinemia, and H-type hypertension. Eur J Prev Cardiol. 2024; 31(9):1092-1103. DOI: 10.1093/eurjpc/zwae022. View

4.
Weikert C, Dierkes J, Hoffmann K, Berger K, Drogan D, Klipstein-Grobusch K . B vitamin plasma levels and the risk of ischemic stroke and transient ischemic attack in a German cohort. Stroke. 2007; 38(11):2912-8. DOI: 10.1161/STROKEAHA.107.486068. View

5.
Al Hageh C, Alefishat E, Ghassibe-Sabbagh M, Platt D, Hamdan H, Tcheroyan R . Homocysteine levels, H-Hypertension, and the MTHFR C677T genotypes: A complex interaction. Heliyon. 2023; 9(6):e16444. PMC: 10238895. DOI: 10.1016/j.heliyon.2023.e16444. View